Nightingale Health Oyj Company Description

Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally.

The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Health Check Remote where health check done remotely.

It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers.

The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.

Nightingale Health Oyj

Country	Finland
Founded	2002
Industry	Health Information Services
Sector	Healthcare
Employees	86
CEO	Teemu Suna

Contact Details

Address: Mannerheimintie 164a Helsinki, 00300 Finland
Phone	358 207301810
Website	nightingalehealth.com

Stock Details

Ticker Symbol	HEALTH
Exchange	Nasdaq Helsinki
Fiscal Year	July - June
Reporting Currency	EUR
SIC Code	8071

Key Executives

Name	Position
Teemu Suna	Founder, Chief Executive Officer and Director
Antti Kangas	Founder, Chief Technology Officer and Director
Satu Saksman	Co-Founder and Chief Operating Officer
Peter Wurtz Ph.D.	Founder and Scientific Director
Pasi Soininen Ph.D.	Founder and Laboratory Director
Tuukka Paavola	Chief Financial Officer
Jeffrey Barrett Ph.D.	Chief Scientific Officer
Minja Salmio	Chief Legal Officer
Salla Ruosaari Ph.D.	Chief Research and Development Officer
Dr. Charles Alessi	Chief Medical Officer